Nalmefene attenuates neural alcohol cue-reactivity in the ventral striatum and subjective alcohol craving in patients with alcohol use disorder

• Published in: Psychopharmacology 2021-08, Vol.238 (8), p.2179-2189
• Main Authors: Karl, Damian, Bumb, J. Malte, Bach, Patrick, Dinter, Christina, Koopmann, Anne, Hermann, Derik, Mann, Karl, Kiefer, Falk, Vollstädt-Klein, Sabine
• Format: Article
• Language: English
• Subjects: Adult; Alcohol use; Alcoholism - diagnostic imaging; Alcoholism - drug therapy; Alcoholism - psychology; Analysis; Biomedical and Life Sciences; Biomedicine; Care and treatment; Caudate-putamen; Corpus striatum; Craving - drug effects; Craving - physiology; Cross-Over Studies; Cues; Desire; Double-Blind Method; Drinking behavior; Female; Functional magnetic resonance imaging; Humans; Image processing; Magnetic Resonance Imaging - methods; Male; Mental disorders; Mesolimbic system; Middle Aged; Naltrexone - analogs & derivatives; Naltrexone - pharmacology; Naltrexone - therapeutic use; Narcotic Antagonists - pharmacology; Narcotic Antagonists - therapeutic use; Neostriatum; Neurosciences; Opioid receptors; Original Investigation; Pharmacology/Toxicology; Photic Stimulation - methods; Placebos; Prospective Studies; Psychiatry; Reinforcement; Substance-related disorders; Ventral Striatum - diagnostic imaging; Ventral Striatum - drug effects; Ventral Striatum - physiology; Young Adult
• ISSN: 0033-3158; 1432-2072; 1432-2072
• DOI: 10.1007/s00213-021-05842-7

Rationale Alcohol use disorder is a common and devastating mental illness for which satisfactory treatments are still lacking. Nalmefene, as an opioid receptor modulator, could pharmacologically support the reduction of drinking by reducing the (anticipated) rewarding effects of alcohol and expanding the range of treatment options. It has been hypothesized that nalmefene acts via an indirect modulation of the mesolimbic reward system. So far, only a few imaging findings on the neuronal response to nalmefene are available. Objectives We tested the effect of a single dose of 18 mg nalmefene on neuronal cue-reactivity in the ventral and dorsal striatum and subjective craving. Methods Eighteen non-treatment-seeking participants with alcohol use disorder (67% male, M = 50.3 ± 13.9 years) with a current high-risk drinking level ( M = 76.9 ± 52 g of pure alcohol per day) were investigated using a cue-reactivity task during functional magnetic resonance imaging (fMRI) in a double-blind, placebo-controlled, cross-over study/design. In addition, self-reported craving was assessed before and after exposure to alcohol cues. Results An a priori defined region of interest (ROI) analysis of fMRI data from 15 participants revealed that nalmefene reduced alcohol cue-reactivity in the ventral, but not the dorsal striatum. Additionally, the subjective craving was significantly reduced after the cue-reactivity task under nalmefene compared to placebo. Conclusion In the present study, reduced craving and cue-reactivity to alcohol stimuli in the ventral striatum by nalmefene indicates a potential anti-craving effect of this drug via attenuation of neural alcohol cue-reactivity.